Ceramide Nanoliposomes Augment the Efficacy of Venetoclax and Cytarabine in Models of Acute Myeloid Leukemia

Thumbnail
View/ Open

Show full item record
Author
Cabot, Myles C.; Khokhlatchev, Andrei V.
URI
http://hdl.handle.net/10342/11778
Subject
 cell death; ceramides; drug resistance 
Date
2022
Citation:
APA:
Cabot, Myles C., & Khokhlatchev, Andrei V.. (January 2022). Ceramide Nanoliposomes Augment the Efficacy of Venetoclax and Cytarabine in Models of Acute Myeloid Leukemia. , (), - . Retrieved from http://hdl.handle.net/10342/11778

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Cabot, Myles C., and Khokhlatchev, Andrei V.. "Ceramide Nanoliposomes Augment the Efficacy of Venetoclax and Cytarabine in Models of Acute Myeloid Leukemia". . . (), January 2022. November 30, 2023. http://hdl.handle.net/10342/11778.
Chicago:
Cabot, Myles C. and Khokhlatchev, Andrei V., "Ceramide Nanoliposomes Augment the Efficacy of Venetoclax and Cytarabine in Models of Acute Myeloid Leukemia," , no. (January 2022), http://hdl.handle.net/10342/11778 (accessed November 30, 2023).
AMA:
Cabot, Myles C., Khokhlatchev, Andrei V.. Ceramide Nanoliposomes Augment the Efficacy of Venetoclax and Cytarabine in Models of Acute Myeloid Leukemia. . January 2022; (): . http://hdl.handle.net/10342/11778. Accessed November 30, 2023.
Collections